313 Results for "

cannabinoids

" in MedChemExpress (MCE) Product Catalog:
Products (313)

313 Results for "cannabinoids" in MCE Product Catalog:

Cat. No.: HY-128040
CAS No.: 443129-35-9
Virodhamine (hydrochloride) is a cannabinoid CB1 receptor partial agonist and cannabinoid CB2 receptor full agonist .
loading...
    loading...
Cat. No.: HY-168418
CAS No.: 2748155-93-1
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

ADB-BINACA is categorized as a synthetic cannabinoid .
loading...
    loading...
Cat. No.: HY-W756790
CAS No.: 2693397-47-4
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

MDMB-FUBINACA metabolite M1 is structurally classified as a synthetic cannabinoid.
loading...
    loading...
Cat. No.: HY-133533
CAS No.: 1883545-42-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

O-2050 is a high affinity cannabinoid CB1 receptor antagonist with a Ki of 2.5 nM. O-2050 inhibits cannabinoid CB2 receptor (Ki=0.2 nM). O-2050 can cause locomotor stimulation in mice .
loading...
    loading...
Cat. No.: HY-150067
CAS No.: 334668-69-8
Purity:  99.89%
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

CB1R Allosteric modulator 5, a selective cannabinoid-1 receptor (CB1R) inverse agonist with an IC50 value of 4.2 μM and EC50 value of >10 μM. CB1R Allosteric modulator 5 can be used for the research of metabolic and obesity .
loading...
    loading...
Cat. No.: HY-W715783
CAS No.: 4707-50-0
Synonyms: Divaric acid; Divarinolic acid; Varinolic acid
Target:  

Drug Intermediate

Research Areas:  

Others

Divarinic acid (also known as Divaric acid, Divarinolic acid, or Varinolic acid) serves as an intermediate in the biosynthetic pathway of phytocannabinoids, and can be used to synthesize the cannabinoid precursor CBGVA .
loading...
    loading...
Cat. No.: HY-N6097
CAS No.: 88360-87-6
Amauromine is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist with Ki and Kb values of 178 nM and 66.6 nM, respectively .
loading...
    loading...
Cat. No.: HY-129304
CAS No.: 55824-09-4
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

(±)-Cannabichromeorcin is a cannabinoid.
loading...
    loading...
Cat. No.: HY-134110
CAS No.: 156910-29-1
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Anandamide (AEA) is an endogenous cannabinoid that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. The biological actions of AEA are terminated by cellular uptake and hydrolysis of the amide bond by the enzyme fatty acid amide hydrolase. Arachidonoyl-N-methyl amide is an analog of anandamide that binds to the human central cannabinoid (CB1) receptor with a Ki of 60 nM. It inhibits rat glial gap junction cell-cell communication 100% at a concentration of 50 μM.
loading...
    loading...
Cat. No.: HY-168357
CAS No.: 55824-14-1
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Cannabiphorol (compound 4d) is a rare cannabinoid closely related to cannabinol. Cannabiphorol has the potential for the research of synergistic effects when combined with other cannabinoids .
loading...
    loading...
Cat. No.: HY-134055
CAS No.: 45280-17-9
Synonyms: Arachidonic acid-N,N-dimethyl amide
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

Anandamide (AEA) is an endogenous cannabinoid that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. The biological actions of AEA are terminated by cellular uptake and hydrolysis of the amide bond by the enzyme fatty acid amide hydrolase. Arachidonoyl-N,N-dimethyl amide is an analog of anandamide that exhibits weak or no binding to the human central cannabinoid (CB1) receptor (Ki >1 μM). It inhibits rat glial gap junction cell-cell communication 100% at a concentration of 50 μM.
loading...
    loading...
Cat. No.: HY-168792
CAS No.: 56469-26-2
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

(±)-9-Nor-9α-hydroxy Hexahydrocannabinol is a cannabinoid-type compound that has strong cannabinoid-like activity in both dogs and mice .
loading...
    loading...
Cat. No.: HY-123594
CAS No.: 157182-47-3
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

R-2 Methanandamide (Compound 2) is a cannabinoid Anandamide (HY-10863) analog with a Ki of 119 nM for the cannabinoid receptor (Ki is determined using rat brain membranes with PMSF) .
loading...
    loading...
Cat. No.: HY-103330
CAS No.: 656804-72-7
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

TC-C 14G (Compd 14g) is a Cannabinoid-1 Receptor (CB1R) inverse agonist, with a Ki of 4 nM and EC50 of 11 nM for HCB1R, respectively .
loading...
    loading...
Cat. No.: HY-118641
CAS No.: 39624-81-2
Purity:  99.90%
Cannabinodiol, a cannabinoid analogue, is a phytocannabinoid .
loading...
    loading...
Cat. No.: HY-126550
CAS No.: 1364933-69-6
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

Azidoindolene 1 is structurally similar to cannabinoid .
loading...
    loading...
Cat. No.: HY-158836
CAS No.: 2748289-69-0
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

NAPIE is structurally similar to known synthetic cannabinoids.
loading...
    loading...
Cat. No.: HY-172069
CAS No.: 2219319-40-9
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

ADB-BICA is structurally classified as a synthetic cannabinoid.
loading...
    loading...
Cat. No.: HY-172082
CAS No.: 2749985-70-2
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

MEP-FUBICA is structurally categorized as a synthetic cannabinoid.
loading...
    loading...
Cat. No.: HY-W754600
CAS No.: 1048973-67-6
Synonyms: CHM-MDA-19
Target:  

Cannabinoid Receptor

Research Areas:  

Others

BZO-CHMOXIZID is a Cannabinoid-like analog .
loading...
    loading...